| Day |
 Date |
Time |
Location |
Topic(s) |
Speaker(s) |
| Tuesday |
03/17/09 |
2:00PM |
Bldg. 10, Room 9S235 (Bunim Room) |
The regulation of lymphocyte recruitment to the human liver |
David Adams, MD, Liver Research Group, Birmingham University, Birmingham, UK |
| Monday |
02/01/09 |
2:00PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Hepatitis C recurrence in liver tranplant recipients: Pathogenesis, outcomes and treatment. |
Xavier Forns, MD, Liver Unit, Hospital Clinic, Barcelona, Spain |
| Tuesday |
11/18/08 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
A novel innate immune mechanism is linked to the action of ribavirin in combination with interferon therapy of hepatitis C |
Emmanuel Thomas, MD PhD, NIDDK |
| Tuesday |
10/14/08 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Antigen-specific T cells in autoimmune hepatitis. |
Barbara Rehermann, Liver Diseases Branch, NIDDK |
| Tuesday |
09/30/08 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
The study of liver disease pathogenesis in the post-genomic era. |
Patrizia Farci, Laboratory of Infectious Diseases, NIAID |
| Tuesday |
08/19/08 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Regulating factors of immunpathology in lymphocytic choriomenigitis virus-induced hepatitis. |
Philipp A. Lang, Ontario Cancer Institute, Toronto |
| Tuesday |
06/17/08 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Zoltan Pos: Investigating the genetic background of IFN-alpha responsiveness. Shuaizheng Jia: Enhancement of HCV replication in culture by attenuating host innate immune responses. |
Zoltan Pos and Shuaizheng Jia, Department of Transfusion Medicine, CC, NIH |
| Tuesday |
05/20/08 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Application of genomics to multiple model systems of HCV infection: new insights into HCV-pathogenesis. |
Kathy Walters, University of Seattle |
| Tuesday |
02/12/08 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Enhancement of hepatitis C cell culture. |
Deborah Taylor, CBER, FDA |
| Tuesday |
11/14/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Gene Expression During Peginterferon and Ribavirin Therapy: Some Clues to Understanding Nonresponse. |
Jordan Feld, Liver Diseases Branch, NIDDK, NIH |
| Tuesday |
10/09/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Use of the HCV/JFH-1 in vitro culture system to probe HCV's interaction with dendritic cells and natural killer cells. |
Barbara Rehermann, Liver Diseases Branch, NIDDK |
| Tuesday |
09/25/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Hepatitis C: The end of the beginning or the beginning of the end? |
Charles Rice, PhD, The Rockefeller University, New York, NY |
| Tuesday |
07/17/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
HCV Potpourri: Residual Virus in Recovered Patients, Stellate Cell Activation and Gene Arrays |
Kei Fujiwara, Robert Allison and Sonia Voiculescu Clinical Center, NIH |
| Tuesday |
05/15/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Hepatitis E Virus: a molecular update |
Suzanne Emerson and Judith Graff, NIAID, NIH |
| Tuesday |
04/15/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
HCV pathogenesis and plasmacytoid DCs - friend or foe? |
Matthew Albert, Institute Pasteur, Paris, France |
| Tuesday |
03/20/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Inhibition and Enhancement of HCV Infection |
Savio Wu, Mount Sinai Medical Center, New York, NY |
| Tuesday |
02/13/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Type I IFN-deficient Pathways and Permissive Culture of HCV in vitro |
Deborah Taylor, FDA |
| Tuesday |
01/09/07 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Persistence of Hepatitis C Virus (HCV) in Chimpanzees is Associated with a Loss of Intrahepatic T cell Function during the Late Acute Phase |
Marian Major, FDA |
| Tuesday |
12/12/06 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Takanobu Kato: Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Culture. Takuya Matsumura: A Novel Class of Amphipathic DNA Polymers Inhibits Hepatitis C Virus Infection by Blocking Viral Entry |
Takanobu Kato and Takuya Matsumura, NIDDK, NIH |
| Tuesday |
10/10/06 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
KIR/HLA Interaction in Viral Infection: Unleashing the Killers |
Golo Ahlenstiel, NIDDK, NIH |
| Tuesday |
09/19/06 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Therapeutic Vaccines for Cancer and for Viruses: What’s in Common; What’s Different and What’s Next |
Francesco M. Marincola, Clinical Center, NIH |
| Tuesday |
06/20/06 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Hepatic NK/NKT Cells, Liver Injury and Repair |
Bin Gao, NIAAA |
| Tuesday |
03/21/06 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Jean-Christophe Meunier, NIAID: Inhibition and Enhancement of HCV Infection. Rodney Russel, NIAID: Mutational Analysis of the Putative HCV Fusion Peptide Using a Pseudotype Virus System. |
Jean Christophe Meunier and Rodney Russel |
| Tuesday |
02/21/06 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
The Difference in Individual HBV Kinetic Patterns During Treatment with Placebo, Polymerase-Inhibitors and IFN - Clinical Implications |
Avidan Neumann, NIDDK |
| Tuesday |
01/17/06 |
4:15PM |
Bldg. 10, Room 9S235 (Bunim Room) |
Hepatitis C Virus and a New Interferon-induced Antiviral Pathwa |
Deborah Taylor, CBER, FDA |